Guide for Authors

  • Ethics in publishing

    The journal and its editorial board fully adhere and comply to the policies and principles of Committee on Publication Ethics (COPE) and this journal is a full member of Committee on Publication Ethics (COPE).

    For information on Ethics in publishing and Ethical guidelines for journal publication see http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-authors/ethics.

    Manuscript Submission
    Submission to this journal proceeds totally online. Use the following guidelines to prepare your article. Via the homepage of this journal (http://ees.elsevier.com/jscs) you will be guided stepwise through the creation and uploading of the various files. The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail and via the author's homepage, removing the need for a hard-copy paper trail.Please submit your article via http://ees.elsevier.com/jscs.

    Please click here to download the author agreement form. It is mandatory to submit the author agreement to complete the submission process. Authors are requested to print the form and sign at the appropriate place provided. The scanned copy of this signed form should be uploaded to confirm the agreement.

    Changes to authorship
    This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:

    Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.

    After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

    Manuscript Preparation
    File preparation and types

    Manuscripts are preferred in Microsoft Word format (.doc files). Documents must be double-spaced, with margins of one inch on all sides. Tables and figures should not appear in the main text, but should be submitted as separate digital files and designated with the appropriate file type. References should be given as provided under Reference section (see References section for example).

    Manuscripts should be compiled in the following order: cover letter; title page; abstract; main text; acknowledgments; declaration of interest statement; appendices (as appropriate); references; tables with captions (on separate pages); figures; figure captions (as a list).

    Journal of Saudi Chemical Society publishes the following manuscript types:

    Original papers

    Reviews

    Short communications

    Book reviews

    Title Page
    A title page should be provided comprising the manuscript title plus the full names and affiliations of all authors involved in the preparation of the manuscript. One author should be clearly designated as the corresponding author and full contact information, including phone number and email address, provided for this person. Three to ten key terms that are not in the title should also be included on the title page. The keywords will assist indexers in cross indexing your article.

    Abstract
    All original articles and reviews should start with an abstract of 250 or fewer words, summarising the central core of knowledge that is the focus of the paper. The recommended format is as a structured abstract, with the following headings for an original article: context, objective, materials and methods, results, discussion and conclusion. For a review article, it should be structured as follows: context, objective, methods (including data sources, study selection and data extraction), results and conclusion. It should be written in an informative style permitting its use, without revision, by abstracting services, give essential details of research findings without further reference to the text, and avoid generalisations and nonessential information.

    Main Text
    Original articles

    The body of the article should include the following sections: introduction; methods; results; discussion; conclusions.

    Introduction: This section should state the relevance and background to the study, and its rationale and purpose.

    Methods: This section should include only information that was available at the time the plan or protocol for the study was being written. You should describe your selection of the observational or experimental participants, identify the methods, apparatus and procedures in sufficient detail to allow others to reproduce the results, and describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Journal of Saudi Chemical Society requires that studies involving humans, both volunteers and patients, or animals be approved by an institutional review board, in accordance with approved published guidelines, prior to actually performing the research and publishing the data. Details including clinical trial registration number must be provided in the methods section if research includes studies conducted on human volunteers. In all studies of plants or animals, specific identification should be made as to the materials used, such as by citation of voucher specimen in herbarium or other collections, quoting name of collector, collection number (or date), place of collection, etc. Botanical nomenclature should be consistent with Index Kewensis, and include Latin binomial, authority, and family at first mention in the abstract and in the text. Authors are advised to consult the International Plant name Index (IPNI) (http:/www.ipni.org) and W3Tropicos (http://mobot.org) web based databases to determine the correct botanical name.

    Results: Present your results in logical sequence in the text, tables, and illustrations. Where biological testing is reported, the results should include IC50 ED50, LD50, MIC, etc. as appropriate.

    Discussion: This should include implications of the findings and their limitations, with reference to all other relevant studies and the possibilities these suggest for future research.

    Conclusions: This must summarize the main paper. Ensure that extrapolations are reasonable and that conclusions are justified by the data presented, and indicate if the study design can be generalized to a broader study population.

    Reviews

    The body of a review article should be a comprehensive, scholarly evidence-based review of the literature, accompanied by critical analysis and leading to reasonable conclusions. Wherever appropriate details of the literature search methodology should be provided, i.e. the databases searched (normally Medline and at least one or two other databases), the search terms and inclusive dates, and any selectivity criteria imposed.

    Wherever possible, use primary resources, avoiding "Data on File", "Poster" or other unpublished references.

    Acknowledgments and Declaration of Interest sections

    Acknowledgments and Declaration of interest sections are different, and each has a specific purpose. The Acknowledgments section details special thanks, personal assistance, and dedications. Contributions from individuals who do not qualify for authorship should also be acknowledged here.

    Declarations of interest, however, refer to statements of financial support and/or statements of potential conflict of interest. Within this section also belongs disclosure of scientific writing assistance (use of an agency or agency/freelance writer), grant support and numbers, and statements of employment, if applicable. For a more detailed list of points to include, please see “Declaration of Interest section” below.

    Acknowledgments section

    Any acknowledgments authors wish to make should be included in a separate headed section at the end of the manuscript preceding any appendices, and before the references section. Please do not incorporate acknowledgments into notes or biographical notes.

    Declaration of Interest section

    All declarations of interest must be outlined under the subheading 'Declaration of interest'. If authors have no declarations of interest to report, this must be explicitly stated. The suggested, but not mandatory, wording in such an instance is: The authors report no declarations of interest. When submitting a paper via EES, the 'Declaration of interest' field is compulsory (authors must either state the disclosures or report that there are none). If this section is left empty authors will not be able to progress with the submission.

    Please see our full Declaration of Interest Policy for further information.

    References
    Text:Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

    Example: ‘‘..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....’’

    List:Number the references (numbers in square brackets) in the list in the order in which they appear in the text.

    Examples:

    Reference to a journal publication:

    [1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article, J. Sci. Commun. 163 (2000) 51–59.

    Reference to a book:

    [2] W. Strunk Jr., E.B. White, The Elements of Style, third ed., Macmillan, New York, 1979.

    Reference to a chapter in an edited book:

    [3] G.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 1999, pp. 281–304.

    Reference to a Electronic Resources:

    [4] Amani S. Awaad, R.M. El-meligy, S.A. Qenawy, A.H. Atta, Gamal A. Soliman (2011). Anti-inflammatory, antinociceptive and antipyretic effects of some desert plants. JSCS [Online]. Available at: http://ipac.kacst.edu.sa/eDoc/2011/191580_1.pdf Accessed on 4 November 2011.

    Periodical abbreviations should follow the style given by Index Medicus.

    Tables
    Tables should be used only when they can present information more efficiently than running text. A maximum of three tables should be added. Care should be taken to avoid any arrangement that unduly increases the depth of a table, and the column heads should be made as brief as possible, using abbreviations liberally. Lines of data should not be numbered nor run numbers given unless those numbers are needed for reference in the text. Columns should not contain only one or two entries, nor should the same entry be repeated numerous times consecutively. Tables should be grouped at the end of the manuscript on separate pages.

    Illustrations
    A maximum of five figures or Illustrations (line drawings, halftones, photos, photomicrographs, etc.) should be submitted as digital files for highest quality reproduction and should follow these guidelines:

    300 dpi or higher

    Sized to fit on journal page

    EPS, JPG, TIFF, or PSD format only

    Submitted as separate files, not embedded in the text

    Legends or captions for figures should be listed on a separate page, double spaced

    Notes on Style
    General Style
    Authors are asked to take into account the diverse audience of the journal. Please avoid the use of terms that might be meaningful only to a local or national audience, or provide a clear explanation where this is unavoidable. However, papers that reflect the particularities of a social and cultural system are acceptable. Some specific points on style follow:

    1. Authors should write in clear, concise US English. Language and grammar should be consistent with Fowler's English Usage; spelling and meaning of words should conform to Webster's Dictionary. If English is not your native language please ensure the manuscript has been reviewed by a native speaker. Please note: extensive rewriting of the text will not be undertaken by the editorial staff.

    2. If the standard of English language is not good, manuscripts will not be sent for further evaluation. We advise authors to review the standard of English thoroughly before submitting their manuscripts.

    3. Latin terminology, including microbiological and species nomenclature, should be italicized.

    4. Use standard convention for human and animal genes and proteins: italics for genes and regular font for proteins, and upper case for human products and lower case for animal products.

    5. "US" is preferred to "American", "USA" to "United States", and "UK" to "United Kingdom".

    6. Double quotation marks rather than single are used unless the "quotation is 'within' another".

    7. Punctuation of common abbreviations should adhere to the following conventions: "e.g."; "i.e."; "cf.". Note that such abbreviations should not generally be followed by a comma or a (double) point/period.

    8. Upper case characters in headings and references should be used sparingly, e.g. only the first word of paper titles, subheadings and any proper nouns begin upper case; similarly for the titles of papers from journals in the references and elsewhere.

    9. Apostrophes should be used sparingly. Thus, decades should be referred to as follows: "The 1980s [not the 1980’s] saw …". Possessives associated with acronyms (e.g. APU), should be written as follows: “The APU's findings that …" but note that the plural is "APUs".

    10. All acronyms for national agencies, examinations, etc., should be spelled out the first time they are introduced in text or references. Thereafter the acronym can be used if appropriate, e.g. "The work of the Assessment of Performance Unit (APU) in the early 1980s …" and subsequently, "The APU studies of achievement …", in a reference " (Department of Education and Science [DES] 1989a) ".

    11. Brief biographical details of significant national figures should be outlined in the text unless it is quite clear that the person concerned would be known internationally. Some suggested editorial comments in a typical text are indicated in the following with square brackets: "From the time of H. E. Armstrong [in the 19th century] to the curriculum development work associated with the Nuffield Foundation [in the 1960s], there has been a shift from constructivism to heurism in the design of [British] science courses".

    12. The preferred local (national) usage for ethnic and other minorities should be used in all papers. For the USA, "African-American", "Hispanic” and "Native American" are used, e.g. "The African-American presidential candidate, Jesse Jackson …"; for the UK, "Afro-Caribbean” (not "West Indian"), etc.

    13. Material to be emphasized by italicisation in the printed version should be italicized in the typescript rather than underlined.

    14. Numbers in text should take the following forms: 300, 3000, 30 000 (not 30,000). Spell out numbers under 10 unless used with a unit of measure, e.g. nine pupils but 9 mm (do not use full stops (periods) within units). For decimals, use the form 0.05 (not .05, × 05 or 0× 05). "%" (not "percent") should be used in typescripts.

    15. Appendices should appear before the references section and after any acknowledgments section. The style of the title is shown by the following example:


    "Appendix C: The random network generator".

    Figures and tables within appendices should continue the sequence of numbering from the main body of the text. Sections within appendices should be numbered, for example, C.1, C.2. Equations in appendices should be numbered, for example, (C 1), (C 2). If there is only one appendix, it is referred to as "the appendix” and not called "Appendix A".

    Abbreviations and nomenclature
    For abbreviations and nomenclature, authors should consult the latest edition of the CSE Style Manual available from the Council of Science Editors, 60 Revue Drive, Suite 500 Northbrook, IL, 60062, USA.

    Footnotes

    Footnotes are not to be used except for designation of the corresponding author of the paper or current address information for an author (if different from that shown in the affiliation). Information concerning grant support of research should appear in a separate Declaration of Interest section at the end of the paper. Acknowledgments of the assistance of colleagues or similar notes of appreciation belong in a separate Acknowledgments section.

    Footnotes to tables should be typed directly below the table and are indicated by the following symbols: ∥ (asterisk or star), † (dagger), ‡ (double dagger), ¶ (paragraph mark), § (section mark), ∥ (parallels), ✓ (number sign). Reinitialize symbol sequence within tables.

    Editorial Policies
    Authorship

    According to the International Committee on Medical Journal Ethics (ICMJE), an author is defined as one who has made substantial contributions to the conception and development of a manuscript. Journal of Saudi Chemical Society adheres to the ICMJE guidelines (http://www.icmje.org/#author), which state that "authorship credit should be based on all of the following: 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or advising it critically for important intellectual content; and 3) final approval of the version to be published"1. All other contributors should be listed as acknowledgments.

    All submissions are expected to comply with the above definition. Changes to the authorship list after submission will result in a query from the publisher requesting written explanation.

    Submission

    Journal of Saudi Chemical society considers all manuscripts on the strict condition that they have been submitted only to Journal of Saudi Chemical Society, that they have not been published already, nor are they under consideration for publication or in press elsewhere. Informa Pharmaceutical Science adheres to the Code of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE).Manuscripts submitted to the journal will then go throughan authenticity test. Manuscripts found to have plagiarized material will be rejected immediately. As per these guidelines, failure to adhere to the above conditions will result in the editor and EES publishing an appropriate correction, a statement of retraction, or enacting a withdrawal of the article. In extreme cases, offending authors may be banned from submitting to EES Journal of Saudi Chemical Society in the future, or reported to their institution’s ethics committee.

    Peer Review

    All manuscripts will be subjected to confidential peer review by experts in the field and, on the basis of reviewers’ feedback, papers will be accepted unconditionally, accepted subject to revision or rejected.

    Ethics and Consent

    Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Identifying information should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published.

    Papers including animal experiments or clinical trials must be conducted with approval by the local animal care or human subject committees, respectively (see below).

    To comply with FDAAA legislation, Journal of Saudi Chemical Society requires trial registration as a condition of publication for all studies involving clinical trials. Trial registration numbers should be included in the abstract, with full details provided in the methods section.

    All manuscripts, except reviews, must include a statement in the Introduction or Methods section that the study was approved by an Investigational Review Board (Human Studies Committee or Ethics Committee or Animal Care and Use Committee), if applicable. Authors who do not have formal ethics review committees should include a statement that their study followed principles in the Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm).

    1 Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Available at: http://www.icmje.org/.

    When a product has not yet been approved by an appropriate regulatory body for the use described in the manuscript, the author must specify that the product is not approved for the use under discussion or that the product is still under investigation.

    Copyright and Permissions
    All queries regarding copyrights should be directed to King Saud University or the Editor-in-Chief of the journal. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article.

    Conflict of Interest All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.

    NIH and Public Access Policy
    Please click herefor Elsevier NIH Policy Statement
    .

    Additional Information

    Proofs

    Online proof correction

    Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.

    If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.

    We will do everything possible to get your article published quickly and accurately - please upload all of your corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.

    Reprints
    Each corresponding author will receive a PDF file of the final version of their article. Reprints of individual articles are available for order at the time authors review page proofs. A discount on reprints is available to authors who order before print publication.

    Further information on Reprints can be found by clicking here.

    Author Inquiries
    For inquiries relating to the submission of articles (including electronic submission) please visit this journal's homepage. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author FAQs (http://www.elsevier.com/authorFAQ) and/or contact Customer Support via http://support.elsevier.com.

Advertisement

advert image